Measurement of serum remnant-like lipoprotein particle-triglyceride (RLP-TG) and RLP-TG/total TG ratio using highly sensitive triglyceride assay reagent

Clinica Chimica Acta

Volumn 412, Issue 1-2, 2011, Pages 71-78

  Nakano, Takamitsu ^a,e   Tokita, Yoshiharu ^a   Nagamine, Takeaki ^a   Tanaka, Akira ^b,c   Okazaki, Mitsuyo ^c   Yatsuzuka, Shinichi ^d   Tamei, Noriko ^d   Shimomura, Younosuke ^d   Ando, Yoshitaka ^d   Akamatsu, Suguru ^e   Fujita, Masaki Q ^f   Nakajima, Katsuyuki ^a,b,d,e,f  

^a GUNMA UNIVERSITY   (Japan)

^b KAGAWA NUTRITION UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d Hidaka Hospital   (Japan)

^e OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Metabolic syndrome; Postprandial hyperlipidemia; Remnant like lipoprotein particles (RLP); RLP cholesterol (RLP C); RLP TG total TG ratio; RLP triglyceride (RLP TG)

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIKE LIPOPROTEIN PARTICLE TRIGLYCERIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; JAPANESE; LIPID ANALYSIS; LIPID METABOLISM; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

BLOOD CHEMICAL ANALYSIS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; DIETARY FATS; FASTING; FEMALE; HUMANS; INDICATORS AND REAGENTS; LIMIT OF DETECTION; LINEAR MODELS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTPRANDIAL PERIOD; REFERENCE VALUES; TIME FACTORS; TRIGLYCERIDES;

EID: 78650512673     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.09.040     Document Type: Article

References (41)

1. Iso H., Naito Y., Sato S., et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 2001, 153:490-499.
2. Nordestgaard B.G., Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298:299-308.
3. Bansal S., Buring J., Rifai N., Mora S., Sacks F.M., Rider P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298:309-316.
4. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 1979, 60:473-485.
5. Robins S.J., Collins D., Wittes J.T., et al. Relation of Gemfibrozil treatment and lipid levels with major coronary events. JAMA 2001, 285:1585-1591.
6. Manninen V., Tenkanen L., Koskinen P., et al. Joint effect of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 1992, 85:37-45.
7. Devaraj S., Vega G., Lange R., Grundy S.M., Jialal I. Remnant-like particle cholesterol levels in patients with dyslipoproteinemia or coronary artery disease. Am J Med 1998, 104:445-450.
8. Kugiyama K., Doi H., Takazoe K., et al. Remnant lipoprotein levels in fasting serum predict coronary events with coronary artery disease. Circulation 1999, 99:2858-2860.
9. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001, 154:229-237.
10. Nakajima K., Nakano T., Moon H.D., et al. The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers. Clin Chim Acta 2009, 404:124-127.
11. Karpe F., Steiner G., Olivecrona T., Carison L.A., Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993, 91:748-758.
12. Okamoto H., Miyai A., Sasase T., et al. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma. Clin Chim Acta 2007, 375:92-98.
13. Inazu A., Nakajima K., Nakano T., et al. Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesterol ester transfer protein (CETP) deficiency. Atherosclerosis 2008, 196:953-957.
14. Ai M., Tanaka A., Shimokado K., et al. A deficiency of cholesteryl ester transfer protein whose serum?remnant-like particle-triglyceride significantly increased, but serum?remnant-like particle-cholesterol did not after an oral fat load. Ann Clin Biochem 2009, 46:457-463.
15. Usui S., Suzuki K., Yamanaka H., et al. Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques. Clin Chim Acta 2002, 317:133-143.
16. Takeichi S., Nakajima Y., Osawa M., et al. The Possible role of remnant-like particles as a risk factor for sudden coronary death. Int J Legal Med 1997, 110:213-219.
17. Takeichi S., Yukawa N., Nakajima Y., et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis 1998, 142:309-315.
18. Takeichi S., Nakajima Y., Yukawa N., et al. Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Leg Med 2001, 3:84-94.
19. Nakajima K., Nakajima Y., Takeichi S., Fujita M.Q. ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases. Atherosclerosis 2007, 194:473-482.
20. Nakajima K., Nakajima Y., Takeichi S., Fujita M.Q. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases. Atherosclerosis 2008, 198:237-246.
21. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin Chem 1998, 44:1224-1232.
22. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases (2007).
23. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993, 223:53-71.
24. Nakajima K., Okazaki M., Tanaka A., et al. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I. J Clin Ligand Assay 1996, 19:177-183.
25. Usui S., Hara Y., Hosaki S., Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002, 43:805-814.
26. Cohn J.S., Marcoux C., Davignon J. Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol 1999, 19:2474-2486.
27. Okazaki M., Usui S., Tada N., Nakano T., Nakajima K. Relation between RLP-triglyceride to RLP-cholesterol ration and particle size distribution in RLP-cholesterol profiles by HPLC. Clin Chim Acta 2000, 296:135-149.
28. Marcoux C., Tremblay M., Nakajima K., Davignon J., Cohn J.S. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J Lipid Res 1999, 40:636-647.
29. Nakajima K., Daimon M., Kamiyama K., et al. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia. Ann Clin Biochem 2007, 44:353-359.
30. Ai M., Tanaka A., Ogita K., et al. Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes. J Am Coll Cardiol 2001, 38:1628-1632.
31. Tanaka A. Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb 2004, 11:322-329.
32. Ooi T.C., Cousins M., Ooi D.S., et al. Postprandial remnant- like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab 2001, 86:3134-3142.
33. Nakajima K, Kobayashi I, Mabuchi H, et al. Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma. Ann Clin Biochem 2010;47:423-31.
34. Twickler T.B., Dallinga-Thie G.M., Cohn J.S., Chapman M.J. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation 2004, 109:1918-1925.
35. Campos E., Nakajima K., Tanaka A., Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 1992, 33:369-380.
36. Schneeman B.O., Kotite L., Todd K.M., Havel R.J. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoprotein B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 1993, 90:2069-2073.
37. Marcoux C., Tremblay M., Fredenrich A., et al. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Atherosclerosis 1998, 139:161-171.
38. Marcoux C., Tremblay M., Fredenrich A., Davignon J. Cohn JS Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Metabolism 2001, 50:112-119.
39. Campos E., Kotite L., Blanche P., et al. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. J Lipid Res 2002, 43:365-374.
40. Ohi K., Shimokawa H., Hiroki J., et al. Remnant lipoproteins from patients with sudden cardiac death enhance cornary vasospastic activity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol 2004, 24:918-922.
41. Nakajima K., Nakano T., Tanaka A., Okazaki M., Tokita Y., Nagamine T. Particle size of apoB48 carrying lipoproteins in postprandial plasma. Atherosclerosis 2010, 83. Supplement 11.